Patient-Reported Outcomes Across Treatment Strategies in Papillary Thyroid Microcarcinoma
This systematic review and meta-analysis found that patients whose PTMC was managed with active surveillance reported equal or better HRQOL than those undergoing surgery. These findings support the importance of incorporating PROs into shared decision-making for low-risk thyroid cancer.
Authors
- Olga Husson
- Rajshri M. Gartland (ORCID: https://orcid.org/0000-0003-2678-2111)
- C. Casey Cunningham
- Jagpreet Chhatwal (ORCID: https://orcid.org/0000-0001-8741-4430)
- Yinin Hu (ORCID: https://orcid.org/0000-0002-4324-9530)
- Jessica Liu McMullin (ORCID: https://orcid.org/0000-0002-6492-4953)
- G. Scott Gazelle
- Matthew M.K. Blanco
- Tessa M. van Ginhoven
- Sam P.J. van Dijk
- J. Shannon Swan
Institutions
- University of Maryland, Baltimore (US)
- University of Maryland Medical Center (US)
- Harvard University (US)
- University of Utah (US)
- Erasmus MC (NL)
- Massachusetts General Hospital (US)
- Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NL)
- Erasmus MC Cancer Institute (NL)
- University of Baltimore (US)
- Massachusetts Institute of Technology (US)
Publication Details
- Journal
- JAMA Otolaryngology–Head & Neck Surgery
- Published
- 2025-12-26
- DOI
- https://doi.org/10.1001/jamaoto.2025.4670
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00